Patients with GLP-1 receptor agonists or dual GIP and GLP-1 receptor agonist use during the 12-month baseline period were excluded, as were those with diabetes, prior metabolic bariatric procedures, or conditions associated with unintentional weight change
No topical ingredient, regardless of mechanism, can accelerate that rate
ED can stem from a variety of physical, hormonal, and emotional factors
It has attracted attention because early clinical trials suggest meaningful weight loss in some people, but it should not be viewed as a proven, universally suitable solution
Its ability to elevate IGF-1 levels over a prolonged period supports gradual fat metabolism and lean muscle retention, making it suitable for those pursuing long-term fat loss and body composition improvements